DG
28
-6
HAL
39
-9
HIG
70
-2
APH
65
-2
CB
50
-4
JNPR
63
4
SE
49
-6
O
31
-4
URBN
50
-12
AEE
38
-12
NRG
60
-2
RHI
40
2
AAP
26
2
TXT
72
-3
BBY
51
2
FLS
57
2
MCD
54
-5
VRTX
64
-4
BRK.B
34
-2
UNH
42
4
DG
28
-6
HAL
39
-9
HIG
70
-2
APH
65
-2
CB
50
-4
JNPR
63
4
SE
49
-6
O
31
-4
URBN
50
-12
AEE
38
-12
NRG
60
-2
RHI
40
2
AAP
26
2
TXT
72
-3
BBY
51
2
FLS
57
2
MCD
54
-5
VRTX
64
-4
BRK.B
34
-2
UNH
42
4
Financhill
Back

Keros Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
27

KROS
Keros Therapeutics

Last Price:
45.71
Seasonality Move:
4.22%
Buy
51

ALNY
Alnylam Pharmaceuticals

Last Price:
242.97
Seasonality Move:
20.36%
Sell
27
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $45.70. The Score for KROS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Alnylam Pharmaceuticals (ALNY) is a Buy

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $243.08. The Score for ALNY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $45.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $243.08
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.79 Sell
Relative Strength Index (14 RSI): 38.41 Sell
Chaikin Money Flow: 239305 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.72 - 49.1) Sell
Bollinger Bands (100): (49.87 - 64.91) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 22.91 Buy
Relative Strength Index (14 RSI): 86.77 Buy
Chaikin Money Flow: -1210062 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (135.8 - 205.74) Buy
Bollinger Bands (100): (136.44 - 176.64) Buy

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.61 Buy
20-day SMA: 47.29 Sell
50-day SMA: 51.65 Sell
200-day SMA: 47.07 Sell
8-day EMA: 45.93 Sell
20-day EMA: 47.34 Sell
50-day EMA: 50.89 Sell
200-day EMA: 50 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 209.44 Buy
20-day SMA: 176.25 Buy
50-day SMA: 159.62 Buy
200-day SMA: 165.96 Buy
8-day EMA: 218.01 Buy
20-day EMA: 188.75 Buy
50-day EMA: 168.9 Buy
200-day EMA: 168.09 Buy

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.46 per share, and an increase next year of $1.83 per share.

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):